Skip to main content

My account

Boston Scientific accounts are for healthcare professionals only.

Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.

My Boston Scientific account

Access your online applications and manage your customer profile.

Manage my Boston Scientific account

Quick Links

Contact a representative
Online education and training
Order products online
Reimbursement resources
Return a product
Customer support

Call customer care

1 (888) 272-1001

Spinal Cord Stimulation (SCS) clinical data and proven therapy outcomes

Advancing clinical leadership in spinal cord stimulation therapy

Boston Scientific’s SCS therapy is PROVEN by clinical data.

Boston Scientific’s SCS therapy is backed by robust, peer-reviewed clinical data demonstrating proven, long-term effectiveness and patient outcomes. 

FAST™ SCS therapy outcomes

Discover the latest clinical data supporting FAST Therapy (Fast-Acting Sub-perception Therapy)

Boston Scientific’s FAST Therapy is backed by multiple prospective and published clinical studies.

FAST Therapy is backed by multiple prospective and published clinical studies that demonstrated:

2-2-3

2 minutes to pain relief5,7†

2 NRS pain score1,2,3,4,5†

3-year outcomes1,4

 †Disclaimer: These outcomes reflect approximated data as determined in the referenced studies.

Access the FAST Therapy studies

Ferro R., et al. (2025)

Automated Sub-perception Neural Dosing to Provide Sustained Spinal Cord Stimulation Therapy

Metzger C., et al. (2025)

Two-year Outcomes Using Fast-Acting Sub-perception Therapy for Spinal Cord Stimulation: Results of a Real-World Multicenter Study in the United States

Bayerl S., et al. (2024)

Two-year Outcomes Using Fast-Acting Sub-perception Therapy for Spinal Cord Stimulation: a European, Real-world, Multicenter Experience

Bayerl S., et al. (2026)

Long-term Outcomes of Fast-Acting Sub-perception SCS: Multinational, Real-world Analysis Across Europe and the United States

Anitescu M., et al. (2026)

Long-term Spinal Cord Stimulation Outcomes Using Fast-Acting Sub-perception Therapy Designed to Engage Surround Inhibition

North J., et al. (2026)

FAST Sub-analysis- SOLIS RCT: 2-Year Outcomes of SCS vs Medical Management in Surgery-Naïve Back Pain Patients

Gage E., et al. (2023)

Rapid Onset of Analgesia during Trial Period Utilizing Fast-Acting Sub-perception Therapy SCS

Robust SCS outcomes

Experience a powerful, flexible SCS system built to deliver truly personalized care

Boston Scientific’s multiple mechanism SCS therapy is backed by Level I RCTs and Real-World Studies.

Boston Scientific’s SCS has robust clinical evidence: 

4X4

4 level 1 RCTs6, 8-11

4 level 1 Real-World Studies12-17

Access the 4 Level I RCTS

PROCO RCT (2018)

With proper neural dosing, 1kHz provides excellent pain relief using less energy7

WHISPER RCT (2020) 

Patients achieve superior outcomes when they can choose between multiple options: sub-perception AND paresthesia8

COMBO RCT (2023) 

Boston Scientific’s proprietary Combination Therapy (Contour + Paresthesia) delivers high clinical and functional success that is sustained for years9

SOLIS RCT

SCS with multiple modalities delivers high clinical and functional success in non-surgical back pain (NSBP) patients that is sustained for years:16, 17 

1-year outcomes (2025) 
2-year outcomes (2026)

Access the 4 Real-World studies

HALO study (2022) 

The Contour™ Algorithm at 200 Hz delivers simple, efficient, and effective sub-perception pain relief11

LUMINA study (2017) 

Using Boston Scientific’s Illumina 3D™ algorithm, paresthesia-based SCS provides excellent pain relief12

WaveWriter™ study

Boston Scientific’s WaveWriter System delivers excellent durable outcomes in the real-world13, 14, 15, 18 

1-year outcomes
 (2020)
2-year outcomes (2022)

RELIEF NSBP registry 

2-year outcomes (2023) 
3-year outcomes (2026)

Salvage success outcomes

Give your patients another option if their SCS therapy is no longer effective

A majority of patients who did not respond to a competitive therapy found pain relief when their leads were connected to the Boston Scientific SCS System.16

60-60 salvage success evidence:

60-60

60% trial salvage18

60% implant salvage19

Access the salvage studies

Rigoard P., et al. (2024)

Improved Outcomes and Therapy Longevity after Salvage Using a Novel Spinal Cord Stimulation System for Chronic Pain: Multicenter, Observational, European Case Series

Haider N., et al. (2018)

Spinal Cord Stimulation (SCS) Trial Outcomes After Conversion to a Multiple Waveform SCS System

REFERENCES:

  1. Ferro R., et al. Automated neural dosing for fast-acting subperception therapy: sustained spinal cord stimulation outcomes from a multicenter study. Pain Ther. 2025;14(4):1417-1429. (n=23)

  2. Metzger C., et al. Two-year outcomes using fast-acting sub-perception therapy for spinal cord stimulation: results of a real-world multicenter study in the United States. Expert Rev Med Devices. 2025;22(2):155-164. (n=50) 

  3. Bayerl S., et al. Two-year outcomes using fast-acting, sub-perception therapy for spinal cord stimulation: a European, real-world, multicenter experience. J Clin Med. 2024;13(22):6999. (n=52)

  4. Bayerl S., et al. Long-term Outcomes of Fast-acting Sub-perception SCS: Multinational, Real-world Analysis across Europe and the United States [Abstract] NANS 2026 Annual Meeting, Jan 22-25, 2026. (n=389) 

  5. Anitescu M., et al. Long-term Spinal Cord Stimulation Outcomes using Fast-Acting Sub-perception Therapy Designed to Engage Surround Inhibition [Abstract] NANS 2026 Annual Meeting, Jan 22-25, 2026. (n=56)

  6. North J., et al. SOLIS RCT: 2-Year Outcomes of SCS vs Medical Management in Surgery-Naïve Back Pain Patients [Abstract] NANS 2026 Annual Meeting, Jan 22-25, 2026. (n=90) 

  7. Gage E., et al. Rapid Onset of Analgesia during Trial Period Utilizing Fast-Acting Sub-Perception Therapy SCS [Abstract] NANS 2023 Annual Meeting, Jan 12-15, 2023. (n=44)

  8. Thomson SJ, Tavakkolizadeh M, Love-Jones S, et al. Effects of rate on analgesia in kilohertz frequency spinal cord stimulation: results of the PROCO randomized controlled trial. Neuromodulation. 2018;21(1):67-76. (n=20) 

  9. North J, Loudermilk E, Lee A, et al. Outcomes of a multicenter, prospective, crossover, randomized controlled trial evaluating subperception spinal cord stimulation at ≤1. 2 khz in previously implanted subjects. Neuromodulation. 2020;23(1):102-108. (n=140)

  10. Wallace MS, North JM, Phillips GM, et al. Combination therapy with simultaneous delivery of spinal cord stimulation modalities: COMBO randomized controlled trial. Pain Management. 2023;13(3):171-184. (n=59) 

  11. North J, Calodney A, Trainor D, et al. Spinal cord stimulation plus conventional medical management versus conventional medical management alone for severe, non-surgical, refractory back pain: a randomized clinical trial followed by crossover. Reg Anesth Pain Med. Published online October 5, 2025:rapm-2024-106335. doi:10.1136/rapm-2024-106335 (n=105)

  12. Paz-Solís J, Thomson S, Jain R, Chen L, Huertas I, Doan Q. Exploration of high- and low-frequency options for subperception spinal cord stimulation using neural dosing parameter relationships: the halo study. Neuromodulation. 2022;25(1):94-102. (n=30) 

  13. Veizi E, Hayek SM, North J, et al. Spinal cord stimulation (SCS) with anatomically guided (3D) neural targeting shows superior chronic axial low back pain relief compared to traditional SCS-LUMINA study. Pain Med. 2017;18(8):1534-1548. (n=169)

  14. Metzger CS, Hammond MB, Pyles ST, et al. Pain relief outcomes using an SCS device capable of delivering combination therapy with advanced waveforms and field shapes. Expert Rev Med Devices. 2020;17(9):951-957. (n=84) 

  15. Metzger C, et al. Long-Term Chronic Pain-Relief Outcomes Using an SCS System Capable of Combination Therapy (WaveWriter Outcomes Study) [Abstract]. Twenty-fifth Annual Meeting of the North American Neuromodulation Society, January 13-15th, 2022. (n=84)

  16. Rauck R. et al. Real-World Outcomes Using Spinal Cord Stimulation for Treatment of Chronic Back Pain with No Prior Back Surgery [Abstract]. Third joint Congress of the INS European Chapters, August 31 – September 2nd, 2023. (n=58) 

  17. Rauck R. et al. Three-Year Outcomes of Spinal Cord Stimulation across Multiple Indications: A Prospective, Global, Real-world Registry [Abstract] NANS 2026 Annual Meeting, Jan 22-25, 2026. (n=516)

  18. Rigoard P, Billot M, Bougeard R, et al. Improved outcomes and therapy longevity after salvage using a novel spinal cord stimulation system for chronic pain: multicenter, observational, European case series. J Clin Med. 2024;13(4):1079. (n=43) 

  19. Haider N, Ligham D, Quave B, et al. Spinal cord stimulation (SCS) trial outcomes after conversion to a multiple waveform SCS system. Neuromodulation. 2018;21(5):504-507. (n=16)

View Boston Scientific Spinal Cord Stimulator System Indications, Safety, and Warnings 

Warning: Stimulation modes. Only paresthesia-based stimulation mode has been evaluated for effectiveness in the diabetic peripheral neuropathy (DPN) population.  

Results from clinical studies are not predictive of results in other studies. Results in other studies may vary.